OBJECTIVES: To compare HIV care quality provided by non-physician clinicians (NPC) and physicians. DESIGN: Retrospective cohort study assessing the relationship between provider cadre and HIV care quality among non-pregnant adult patients initiating antiretroviral therapy (ART) in the national HIV care programme. METHODS: Computerized medical records from patients initiating ART between July 2004 and October 2007 at two HIV public HIV clinics in central Mozambique were used to develop multivariate analyses evaluating differences in process and care continuity measures for patients whose initial provider was a NPC or physician. RESULTS: A total of 5892 patients was included in the study, including 4093 (69.5%) with NPC and 1799 (30.5%) with physicians as initial providers. Those whose initial provider was a NPC were more likely to have a CD4 cell count 90-210 days [risk ratio (RR) 1.13, 1.04<RR<1.23] and 330-390 days (RR 1.12, 0.96<RR<1.31) after initiating ART. A large majority of patients adhered well to care, although patients whose initial provider was a NPC had more frequent clinical visits in the first year post-ART initiation (RR 1.02, 1.00<RR<1.05) and higher levels of adherence to antiretroviral medicines in the first 6 months after initiating ART (RR1.05, 1.02<RR<1.09). Patients of NPC were less likely to be lost to follow-up than those seen by physicians (RR 0.86, 0.73<RR<1.02). CONCLUSION: NPC performance was similar to or better than that of physicians for the HIV care quality study measures. Our results highlight the important role of NPC in scaling up ART in Mozambique, and argue for using all relevant clinical resources to meet the large demands for care in countries with high HIV burdens.
OBJECTIVES: To compare HIV care quality provided by non-physician clinicians (NPC) and physicians. DESIGN: Retrospective cohort study assessing the relationship between provider cadre and HIV care quality among non-pregnant adult patients initiating antiretroviral therapy (ART) in the national HIV care programme. METHODS: Computerized medical records from patients initiating ART between July 2004 and October 2007 at two HIV public HIV clinics in central Mozambique were used to develop multivariate analyses evaluating differences in process and care continuity measures for patients whose initial provider was a NPC or physician. RESULTS: A total of 5892 patients was included in the study, including 4093 (69.5%) with NPC and 1799 (30.5%) with physicians as initial providers. Those whose initial provider was a NPC were more likely to have a CD4 cell count 90-210 days [risk ratio (RR) 1.13, 1.04<RR<1.23] and 330-390 days (RR 1.12, 0.96<RR<1.31) after initiating ART. A large majority of patients adhered well to care, although patients whose initial provider was a NPC had more frequent clinical visits in the first year post-ART initiation (RR 1.02, 1.00<RR<1.05) and higher levels of adherence to antiretroviral medicines in the first 6 months after initiating ART (RR1.05, 1.02<RR<1.09). Patients of NPC were less likely to be lost to follow-up than those seen by physicians (RR 0.86, 0.73<RR<1.02). CONCLUSION:NPC performance was similar to or better than that of physicians for the HIV care quality study measures. Our results highlight the important role of NPC in scaling up ART in Mozambique, and argue for using all relevant clinical resources to meet the large demands for care in countries with high HIV burdens.
Authors: Charles F Gilks; Siobhan Crowley; René Ekpini; Sandy Gove; Jos Perriens; Yves Souteyrand; Don Sutherland; Marco Vitoria; Teguest Guerma; Kevin De Cock Journal: Lancet Date: 2006-08-05 Impact factor: 79.321
Authors: I K Warriner; O Meirik; M Hoffman; C Morroni; J Harries; N T My Huong; N D Vy; A H Seuc Journal: Lancet Date: 2006-12-02 Impact factor: 79.321
Authors: Stephen M Shortell; Jill A Marsteller; Michael Lin; Marjorie L Pearson; Shin-Yi Wu; Peter Mendel; Shan Cretin; Mayde Rosen Journal: Med Care Date: 2004-11 Impact factor: 2.983
Authors: M O Mundinger; R L Kane; E R Lenz; A M Totten; W Y Tsai; P D Cleary; W T Friedewald; A L Siu; M L Shelanski Journal: JAMA Date: 2000-01-05 Impact factor: 56.272
Authors: Ashwin Vasan; Nathan Kenya-Mugisha; Kwonjune J Seung; Marion Achieng; Patrick Banura; Frank Lule; Megan Beems; Jim Todd; Elizabeth Madraa Journal: Hum Resour Health Date: 2009-08-20
Authors: Barrot H Lambdin; Mark A Micek; Thomas D Koepsell; James P Hughes; Kenneth Sherr; James Pfeiffer; Marina Karagianis; Joseph Lara; Stephen S Gloyd; Andy Stergachis Journal: J Acquir Immune Defic Syndr Date: 2011-07-01 Impact factor: 3.731
Authors: Edward J Mills; Richard Lester; Kristian Thorlund; Maria Lorenzi; Katherine Muldoon; Steve Kanters; Sebastian Linnemayr; Robert Gross; Yvette Calderon; K Rivet Amico; Harsha Thirumurthy; Cynthia Pearson; Robert H Remien; Lawrence Mbuagbaw; Lehana Thabane; Michael H Chung; Ira B Wilson; Albert Liu; Olalekan A Uthman; Jane Simoni; David Bangsberg; Sanni Yaya; Till Bärnighausen; Nathan Ford; Jean B Nachega Journal: Lancet HIV Date: 2014-11-24 Impact factor: 12.767
Authors: Alana T Brennan; Lawrence Long; Mhairi Maskew; Ian Sanne; Imogen Jaffray; Patrick MacPhail; Matthew P Fox Journal: AIDS Date: 2011-10-23 Impact factor: 4.177
Authors: Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds Journal: Lancet Infect Dis Date: 2013-01 Impact factor: 25.071
Authors: Barrot H Lambdin; Mark A Micek; Kenneth Sherr; Sarah Gimbel; Marina Karagianis; Joseph Lara; Stephen S Gloyd; James Pfeiffer Journal: J Acquir Immune Defic Syndr Date: 2013-04-15 Impact factor: 3.731
Authors: Bradley H Wagenaar; Sarah Gimbel; Roxanne Hoek; James Pfeiffer; Cathy Michel; João Luis Manuel; Fatima Cuembelo; Titos Quembo; Pires Afonso; Stephen Gloyd; Kenneth Sherr Journal: Trop Med Int Health Date: 2014-04-11 Impact factor: 2.622